A Review On Rheumatic Disease Awareness
DOI:
https://doi.org/10.63682/jns.v14i29S.6795Keywords:
RHD, ARF, Epidemiology, Importance, Barriers, Strategies Awareness, KnowledgeAbstract
ARF/RHD are conditions associated with low socioeconomic status and insufficient access to healthcare services. Despite their capacity to inflict considerable mortality and morbidity in low-income regions, these preventable diseases frequently receive insufficient attention in developed countries. To tackle the absence of a definitive treatment, it is essential to prioritize prevention and control strategies. It is essential to enhance understanding of the disease and its effects on millions of individuals globally. Thus in this review we have address the awareness and knowledge globally by understanding its epidemiology, importance,barriers and different strategies that can be used for RHD.
Downloads
Metrics
References
Bryant PA, Robins-Browne R, Carapetis JR, Curtis N. Some of the people, some of the time: susceptibility to acute rheumatic fever. Circulation. 2009 Feb 10;119(5):742-53.
Gewitz MH, Baltimore RS, Tani LY, Sable CA, Shulman ST, Carapetis J, Remenyi B, Taubert KA, Bolger AF, Beerman L, Mayosi BM. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation. 2015 May 19;131(20):1806-18.
Karthikeyan G, Guilherme L. Acute rheumatic fever. The Lancet. 2018 Jul 14;392(10142):161-74.
Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, Mayosi BM, Sable C, Steer A, Wilson N, Wyber R, Zühlke L. Acute rheumatic fever and rheumatic heart disease. Nature reviews Disease primers. 2016 Jan 14;2(1):1-24.
Watkins DA, Beaton AZ, Carapetis JR, Karthikeyan G, Mayosi BM, Wyber R, Yacoub MH, Zühlke LJ. Rheumatic heart disease worldwide: JACC scientific expert panel. Journal of the American College of Cardiology. 2018 Sep 18;72(12):1397-416.
Leal MT, Passos LS, Guarçoni FV, Aguiar JM, Silva RB, Paula TM, Santos RF, Nassif MC, Gomes NF, Tan TC, Nunes MC. Rheumatic heart disease in the modern era: recent developments and current challenges. Revista da Sociedade Brasileira de Medicina Tropical. 2019 Mar 14;52(00):e20180041.
Zilla P, Bolman RM, Yacoub MH, Beyersdorf F, Sliwa K, Zühlke L, Higgins RS, Mayosi B, Carpentier A, Williams D. The Cape Town declaration on access to cardiac surgery in the developing world. European Journal of Cardio-Thoracic Surgery. 2018 Sep 1;54(3):407-10.
Zühlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B, Mauff K, Islam S, Joachim A, Daniels R, Francis V. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). European heart journal. 2015 May 7;36(18):1115-22.
Passos LS, Nunes MC, Zilla P, Yacoub MH, Aikawa E. Raising awareness for rheumatic mitral valve disease. Global Cardiology Science & Practice. 2020 Nov 30;2020(2):e202026.
Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. The Lancet. 2012 Mar 10;379(9819):953-64.
Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. European heart journal. 2010 Mar 1;31(6):719-27.
Scherman J, Bezuidenhout D, Ofoegbu C, Williams DF, Zilla P. Erratum to:‘TAVI for low to middle income countries’[Eur Heart J (2017); 38 (16): 1182-1184]. An error occurred with the order of the authors in the article “TAVI for low to middle income countries” which appeared in the Eur Heart J (2017) 38 (16): 1182-1184.
Sliwa K, Zilla P. Rheumatic heart disease: the tip of the iceberg. Circulation. 2012 Jun 26;125(25):3060-2.
Carapetis JR. The stark reality of rheumatic heart disease. European heart journal. 2015 May 7;36(18):1070-3.
Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, Forouzanfar MH, Longenecker CT, Mayosi BM, Mensah GA, Nascimento BR. Global, regional, and national burden of rheumatic heart disease, 1990–2015. New england journal of medicine. 2017 Aug 24;377(8):713-22.
Saxena A, Zühlke L, Wilson N. Echocardiographic screening for rheumatic heart disease: issues for the cardiology community. Global heart. 2013 Sep 1;8(3):197-202.
Engelman D, Wheaton GR, Mataika RL, Kado JH, Colquhoun SM, Remenyi B, Steer AC. Screening-detected rheumatic heart disease can progress to severe disease. Heart Asia. 2016 Jul 1;8(2):67-73.
Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, Paquet C, Jacob S, Sidi D, Jouven X. Prevalence of rheumatic heart disease detected by echocardiographic screening. New England Journal of Medicine. 2007 Aug 2;357(5):470-6.
Beaton A, Okello E, Lwabi P, Mondo C, McCarter R, Sable C. Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation. 2012 Jun 26;125(25):3127-32.
Roberts K, Maguire G, Brown A, Atkinson D, Reményi B, Wheaton G, Kelly A, Kumar RK, Su JY, Carapetis JR. Echocardiographic screening for rheumatic heart disease in high and low risk Australian children. Circulation. 2014 May 13;129(19):1953-61.
Rothenbühler M, O'Sullivan CJ, Stortecky S, Stefanini GG, Spitzer E, Estill J, Shrestha NR, Keiser O, Jüni P, Pilgrim T. Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. The Lancet Global Health. 2014 Dec 1;2(12):e717-26.
Nascimento BR, Beaton AZ, Diamantino AC, Nunes MD, Reese AT, Oliveira KK, Carmo GA, Lourenço TV, Ruiz GZ, Rabelo LM, Ribeiro AL. Comparison between different strategies of rheumatic heart disease echocardiographic screening in brazil: Data from the provar study. Circulation. 2017 Nov 14;136(suppl_1):A17808-.
Passos LS, Nunes MC, Zilla P, Yacoub MH, Aikawa E. Raising awareness for rheumatic mitral valve disease. Global Cardiology Science & Practice. 2020 Nov 30;2020(2):e202026.
O ga sSullivan GA, Yonkler JA, Morgan W, Merritt AP. A field guide to designing a health communication strategy: A resource for health communication professionals. InA field guide to designing a health communication strategy: a resource for health communication professionals 2003 (pp. 308-308).
Moran M, Guzman J, Ropars AL, McDonald A, Jameson N, Omune B, Ryan S, Wu L. Neglected disease research and development: how much are we really spending?. PLoS medicine. 2009 Feb;6(2):e1000030.
Zühlke L, Mirabel M, Marijon E. Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities. Heart. 2013 Nov 1;99(21):1554-61.
Nkgudi B, Robertson KA, Volmink J, Mayosi BM. Notification of rheumatic fever in South Africa-evidence for underreporting by health care professionals and administrators. South African medical journal. 2006 Mar 1;96(3):206-8.
Gersh BJ, Sliwa K, Mayosi BM, Yusuf S. Novel therapeutic concepts the epidemic of cardiovascular disease in the developing world: global implications. European heart journal. 2010 Mar 1;31(6):642-8.
Broder S, Hoffman SL, Hotez PJ. Cures for the Third World's problems. EMBO reports. 2002 Sep 1.
Bergmark R, Bergmark B, Blander J, Fataki M, Janabi M. Burden of disease and barriers to the diagnosis and treatment of group a beta-hemolytic streptococcal pharyngitis for the prevention of rheumatic heart disease in Dar Es Salaam, Tanzania. The Pediatric infectious disease journal. 2010 Dec 1;29(12):1135-7.
Mayosi BM. The four pillars of rheumatic heart disease control. SAMJ: South African Medical Journal. 2010 Aug;100(8):506-.
Parnaby MG, Carapetis JR. Rheumatic fever in indigenous Australian children. Journal of paediatrics and child health. 2010 Sep;46(9):527-33.
Mayosi BM, Lawn JE, Van Niekerk A, Bradshaw D, Karim SS, Coovadia HM. Health in South Africa: changes and challenges since 2009. The lancet. 2012 Dec 8;380(9858):2029-43.
David RA, Rhee M. The impact of language as a barrier to effective health care in an underserved urban Hispanic community. The Mount Sinai Journal of Medicine, New York. 1998 Oct 1;65(5-6):393-7.
Alleyne G, Binagwaho A, Haines A, Jahan S, Nugent R, Rojhani A, Stuckler D. Embedding non-communicable diseases in the post-2015 development agenda. The Lancet. 2013 Feb 16;381(9866):566-74.
Bottles K. Twitter: an essential tool for every physician leader. Physician Executive. 2011 May 1;37(3):80.
Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P. Framework for design and evaluation of complex interventions to improve health. Bmj. 2000 Sep 16;321(7262):694-6.
Cohen E, Lacombe-Duncan A, Spalding K, MacInnis J, Nicholas D, Narayanan UG, Gordon M, Margolis I, Friedman JN. Integrated complex care coordination for children with medical complexity: a mixed-methods evaluation of tertiary care-community collaboration. BMC health services research. 2012 Dec;12:1-1.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
